29 reports

Abstract: What’s New for 2022? -Global competitiveness and key competitor percentage market shares -Market presence across multiple geographies - Strong/Active/Niche/Trivial -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass...

  • Diagnostics
  • Lung Cancer
  • World
  • China
  • United States
  • Europe
  • Japan
  • APAC
  • Canada

Major players in the cancer biologics market are AbbVie Inc., Hoffman-La Roche, GlaxoSmithKline, Eli Lilly and Company, and Amgen Inc. The global cancer biologics market is expected to grow from $66.12 billion in 2020 to $70.69 billion in 2021 at a compound annual growth rate (CAGR) of 6.9%. The growth is mainly due to the companies...

  • Biopharmaceutical
  • World
  • United States
  • APAC
  • Chronic Disease Prevalence
  • Drug Approval

United States Air Purifier Market, By Filter Type (HEPA + Activated Carbon, Pre-Filter + HEPA, HEPA and Others (Ion & Ozone, Electrostatic precipitator, HEPA+ Activated Carbon+ Ion Ozone, etc.), By End Use (Non-Residential/Commercial, Residential/Household), By Distribution Channel (Direct/Institutional Sales, Offline Retail Sales,...

  • Air Purifier
  • United States
  • Online Retail Sales
  • Air Quality Index

Major players in the cancer biologics market are AbbVie Inc., Hoffman-La Roche, GlaxoSmithKline, Eli Lilly and Company, Amgen Inc., Bristol-Myers Squibb Company, Johnson & Johnson, Merck & Co. Inc., Novartis and Pfizer. The global cancer biologics market is expected to grow from $76.46 billion in 2021 to $86.64 billion in 2022 at a...

  • Cancer
  • Biopharmaceutical
  • World
  • Middle East
  • United States
  • APAC
  • Chronic Disease Prevalence
  • Drug Approval

United States Diagnostics Market, By Product Type (Reagents, Instruments, Software & Services), By Type of Test (Infectious Disease Testing, Lipid Panel, Metabolic Panel, Others), By Technique (Immunodiagnostics, Clinical Techniques, Molecular Diagnostics, Tissue Diagnostics, Others), By Usability (Reusable v/s Disposable), By Application...

  • Diagnostics
  • United States

Report Scope: This research report presents an in-depth analysis of the global cancer stem cells market by cancer type and geographic markets.The report includes key inhibitors that affect various factors that help in growth of cancer stem cells. The report discusses the roles of supply chain members from manufacturers...

  • Cancer
  • Immunotherapy
  • Therapy
  • World
  • Mortality Rate
  • Cancer Incidence

Global Viral Vectors Market: About this market This viral vectors market analysis considers sales from both gene therapy and vaccines applications. Our study also finds the sales of viral vectors in Asia, Europe, North America, and ROW. In 2019, the gene therapy segment had a significant market share, and this trend is...

  • Gene Therapy
  • World
  • Chronic Disease Prevalence

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares -Market presence across multiple geographies - Strong/Active/Niche/Trivial -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass...

  • Oncology
  • World
  • Fuel Sales

About this market The recent approvals of chemotherapeutics to treat cancer is one of the key factors expected to trigger the chemotherapy treatment market during the forecast period. With the rising prevalence of cancer, the demand for chemotherapeutics agents is increasing. The market has witnessed recent approvals...

  • Chemotherapy
  • World

KEY FINDINGS The Asia-Pacific cancer biomarkers market is expected to speed up its growth with a CAGR of 15.73% for the years 2017-2025, generating a net worth of $8831 million. India is the fastest growing market in the Asia-Pacific region. MARKET INSIGHTS The market is mainly categorized into diseases and discovery...

  • Biomarker
  • APAC

Global Chemotherapy-induced Nausea and Vomiting (CINV) Market (Patient Pool Type: Aloxi, Kytril, Emend, and Netupitant-Palonosetron) - Global Opportunities and Forecast 2014-2022 Nausea and vomiting is one of the common side effects of chemotherapy in the cancer patients. Because of such side effects the patient population either...

  • Chemotherapy
  • World
  • Cancer Incidence

IsoRay, Inc. (USA)

1272 1450 1131

This report presents quick facts about IsoRay, Inc., which is principally involved in the Manufacture of Isotope-Based Medical Products and Devices. Illustrated with 29 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

This report presents quick facts about Loxo Oncology, Inc., which is principally involved in Pharmaceuticals Business. Illustrated with 46 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

  • Pharmaceutical
  • United States

Biocept, Inc. (USA)

2412 2750 2145

This report presents quick facts about Biocept, Inc., which is principally involved in Cancer Diagnostics Business. Illustrated with 55 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

  • Cancer Diagnostics
  • United States

This report presents quick facts about Celldex Therapeutics, Inc., which is principally involved in Biopharmaceuticals Business. Illustrated with 42 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

  • Biopharmaceutical
  • United States

Xbiotech, Inc. (USA)

1842 2100 1638

This report presents quick facts about Xbiotech, Inc., which is principally involved in Biopharmaceuticals Business. Illustrated with 42 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

  • Biopharmaceutical
  • United States

This report presents quick facts about Trillium Therapeutics, Inc., which is principally an Immuno-Oncology Company. Illustrated with 48 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

This report presents quick facts about Helix Biopharma Corporation, which is principally involved in Biopharmaceuticals Business. Illustrated with 52 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

  • Biopharmaceutical
  • Canada

This report presents quick facts about Oncolytics Biotech, Inc., which is principally involved in Biotechnology Business. Illustrated with 52 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

  • Biotechnology
  • Canada

This report presents quick facts about Actinium Pharmaceuticals, Inc., which is principally involved in Biopharmaceuticals Business. Illustrated with 52 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

  • Biopharmaceutical
  • United States

This report presents quick facts about Affimed N.V., which is principally a Clinical-Stage Biopharmaceutical Company. Illustrated with 53 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

  • Biopharmaceutical
  • Germany

This report presents quick facts about Blueprint Medicines Corporation, which is principally involved in Biopharmaceuticals Business. Illustrated with 52 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

  • Biopharmaceutical
  • United States

This report presents quick facts about Can Fite Biofarma Ltd., which is principally a Clinical-Stage Biopharmaceutical Company. Illustrated with 52 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

  • Biopharmaceutical
  • Israel

This report presents quick facts about Celator Pharmaceuticals, Inc., which is principally a Clinical Stage Biopharmaceutical Company. Illustrated with 52 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

  • Biopharmaceutical
  • United States

This report presents quick facts about Dicerna Pharmaceuticals, Inc., which is principally involved in Biopharmaceuticals Business. Illustrated with 53 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

  • Biopharmaceutical
  • United States

This report presents quick facts about Coherus BioSciences, Inc., which is principally a Late-Stage Clinical Biologics Platform. Illustrated with 55 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

This report presents quick facts about TRACON Pharmaceuticals, Inc., which is principally a Clinical Stage Biopharmaceutical Company. Illustrated with 55 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

  • Biopharmaceutical
  • United States

This report presents quick facts about Cellectar Biosciences, Inc., which is principally involved in Biopharmaceuticals Business. Illustrated with 73 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

  • Biopharmaceutical
  • United States

This report presents quick facts about TrovaGene, Inc., which is principally involved in Molecular Diagnostics Business. Illustrated with 37 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

  • Molecular Diagnostics
  • United States